MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
02 2019
Historique:
received: 26 07 2018
accepted: 27 10 2018
pubmed: 16 11 2018
medline: 2 4 2020
entrez: 16 11 2018
Statut: epublish

Résumé

Although pyrazinamide (PZA) is a key component of first- and second-line tuberculosis treatment regimens, there is no gold standard to determine PZA resistance. Approximately 50% of multidrug-resistant tuberculosis (MDR-TB) and over 90% of extensively drug-resistant tuberculosis (XDR-TB) strains are also PZA resistant.

Identifiants

pubmed: 30429257
pii: JCM.01162-18
doi: 10.1128/JCM.01162-18
pmc: PMC6355525
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Pyrazinamide 2KNI5N06TI

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P019978/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P019978/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 099805/Z/12/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Alcántara et al.

Références

Emerg Infect Dis. 2017 Mar;23(3):491-495
pubmed: 28221108
Tubercle. 1985 Sep;66(3):219-25
pubmed: 3931319
Eur Respir J. 2013 May;41(5):1163-71
pubmed: 22903960
Tuberculosis (Edinb). 2012 Jan;92(1):84-91
pubmed: 22004792
Antimicrob Agents Chemother. 1988 Jul;32(7):1002-4
pubmed: 3142340
ACS Infect Dis. 2015 May 8;1(5):203-214
pubmed: 26086040
BMC Infect Dis. 2017 Nov 6;17(1):711
pubmed: 29110640
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):894-901
pubmed: 28786798
Antimicrob Agents Chemother. 2012 Mar;56(3):1253-7
pubmed: 22203587
Antimicrob Agents Chemother. 2011 Oct;55(10):4499-505
pubmed: 21768515
Indian J Tuberc. 2010 Oct;57(4):207-12
pubmed: 21141339
Antimicrob Agents Chemother. 1997 Mar;41(3):540-3
pubmed: 9055989
PLoS One. 2011;6(11):e27654
pubmed: 22102918
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6766-6773
pubmed: 27600032
Tuberculosis (Edinb). 2016 Jul;99:41-6
pubmed: 27450003
Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21
pubmed: 12701830
Tuberc Res Treat. 2017;2017:3748163
pubmed: 29250443
Lancet. 2018 Sep 8;392(10150):821-834
pubmed: 30215381
Am Rev Respir Dis. 1974 Jan;109(1):147-51
pubmed: 4203284
Nat Commun. 2017 Sep 19;8(1):588
pubmed: 28928454
BMC Infect Dis. 2017 Jul 12;17(1):491
pubmed: 28697808
PLoS Med. 2009 Feb 10;6(2):e2
pubmed: 19209951
PLoS One. 2013;8(2):e55872
pubmed: 23409072
Tuberculosis (Edinb). 2016 Jul;99:128-30
pubmed: 27450014
Int J Tuberc Lung Dis. 2014 Feb;18(2):227-32
pubmed: 24429318
J Clin Microbiol. 2014 Jan;52(1):260-7
pubmed: 24226918
PLoS One. 2015 Jul 28;10(7):e0133869
pubmed: 26218737
J Clin Microbiol. 1991 Nov;29(11):2578-86
pubmed: 1685494
Sci Rep. 2017 Jun 19;7(1):3790
pubmed: 28630430
BMC Infect Dis. 2016 May 17;16:205
pubmed: 27184366
Antimicrob Agents Chemother. 2003 Nov;47(11):3672-3
pubmed: 14576145
J Bacteriol. 1999 Apr;181(7):2044-9
pubmed: 10094680
Adv Med Sci. 2016 Mar;61(1):63-71
pubmed: 26521205
J Clin Microbiol. 2015 Dec;53(12):3779-83
pubmed: 26378284
Stat Med. 1999 Nov 30;18(22):2987-3003
pubmed: 10544302
Indian J Med Res. 2010 Jul;132:72-6
pubmed: 20693593
N Engl J Med. 2006 Oct 12;355(15):1539-50
pubmed: 17035648
J Clin Microbiol. 2016 May;54(5):1276-81
pubmed: 26912751
J Antimicrob Chemother. 2003 Nov;52(5):790-5
pubmed: 14563891
Am J Respir Crit Care Med. 2011 May 15;183(10):1427-33
pubmed: 21297071
Emerg Microbes Infect. 2017 Oct 11;6(10):e86
pubmed: 29018250
J Clin Microbiol. 2013 May;51(5):1374-80
pubmed: 23390285

Auteurs

Roberto Alcántara (R)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Patricia Fuentes (P)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Ricardo Antiparra (R)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Marco Santos (M)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Robert H Gilman (RH)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Daniela E Kirwan (DE)

Institute for Infection and Immunity, St. George's, University of London, London, United Kingdom.

Mirko Zimic (M)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.

Patricia Sheen (P)

Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru patricia.sheen@upch.pe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH